title: [Treatment with psychopharmaca during pregnancy - part I: as little as possible but as much as necessary].
authors.affiliation: Gynäkologische Psychosomatik, Zentrum für Geburtshilfe und Frauenheilkunde, Universitätsklinikum Bonn. anke.rohde@ukb.uni-bonn.de
authors.forename: A
authors.initials: A
authors.lastname: Rohde
authors.forename: V M
authors.initials: VM
authors.lastname: Dorsch
authors.forename: C
authors.initials: C
authors.lastname: Schaefer
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D018692:Antimanic Agents / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003267:Contraception; D005260:Female; D005298:Fertility; D006801:Humans; D018020:Lithium Compounds / Q000009:adverse effects / Q000627:therapeutic use; D001523:Mental Disorders / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000523:psychology*; D011619:Psychotropic Drugs / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D018570:Risk Assessment
chemical_list: D000927:Anticonvulsants; D000928:Antidepressive Agents; D018692:Antimanic Agents; D014150:Antipsychotic Agents; D018020:Lithium Compounds; D011619:Psychotropic Drugs